----

----

| þ | Quarterly Report Under Section 13 or 15(d) of the Securities Exchange Act of 1934 |
|--------|-----------------------------------------------------------------------------------|

| o | Transition Report Under Section 13 or 15(d) of the Securities Exchange Act of 1934 |
|---|------------------------------------------------------------------------------------|

| Delaware                                                       |   | 04-3683628                           |
|----------------------------------------------------------------|--------|--------------------------------------|
| (State or other jurisdiction of incorporation or organization) |   | (IRS Employer Identification Number) |

| Large accelerated filer  ̈                                             |   | Accelerated filer  ̈         |
|----------------------------------------------------------------------------|--------|----------------------------------|
|                                                                       |   |                             |
| Non-accelerated filer  ̈ (Do not check if a smaller reporting company) |   | Smaller reporting company þ |

----

|                                                                           |                                                                                                             | Page   |   |
|--------------------------------------------------------------------------------|------------------------------------------------------------------------------------------------------------------|--------|--------|
| Part I - Financial Information                                                 |                                                                                                             |   |
|                                                                           |                                                                                                             |   |   |
| Item 1:  Financial Statements                                        |                                                                                                             |   |
|                                                                           |                                                                                                             |   |   |
|                                                                           | Condensed Balance Sheets as of April 30, 2011 (unaudited) and as ofOctober 31, 2010                              | 3      |   |
|                                                                           |                                                                                                             |   |   |
|                                                                           | Unaudited Condensed Statements of Operations for the three and sixmonths ended April 30, 2011 and April 30, 2010 | 4      |   |
|                                                                           |                                                                                                             |   |   |
|                                                                           | Unaudited Condensed Statements of Cash Flows for the six monthsEnded April 30 2011 and April 30, 2010            | 5      |   |
|                                                                           |                                                                                                             |   |   |
|                                                                           | Notes to Unaudited Condensed Financial Statements                                                                | 6      |   |
|                                                                           |                                                                                                             |   |   |
| Item 2:  Management's Plan of Operation                              |                                                                                                             |   |
|                                                                           |                                                                                                             |   |   |
|                                                                           | Management's Discussion and Analysis of Financial Condition                                                      |   |   |
|                                                                           | and Results of Operations                                                                                        | 12     |   |
|                                                                           |                                                                                                             |   |   |
| Item 3.  Quantitative and Qualitative Disclosures about Market Risk  | 14                                                                                                               |   |
|                                                                           |                                                                                                             |   |   |
| Item 4.  Controls and Procedures                                     | 14                                                                                                               |   |
|                                                                           |                                                                                                             |   |   |
| Part II - Other Information                                                    |                                                                                                             |   |
|                                                                           |                                                                                                             |   |   |
| Item 1:  Legal Proceedings                                           | 15                                                                                                               |   |
|                                                                           |                                                                                                             |   |   |
| Item 2:  Unregistered Sales of Equity Securities and Use of Proceeds | 15                                                                                                               |   |
|                                                                           |                                                                                                             |   |   |
| Item 3.  Defaults Upon Senior Securities                             | 15                                                                                                               |   |
|                                                                           |                                                                                                             |   |   |
| Item 4:  Removed and Reserved                                        | 15                                                                                                               |   |
|                                                                           |                                                                                                             |   |   |
| Item 5:  Other Information                                           | 15                                                                                                               |   |
|                                                                           |                                                                                                             |   |   |
| Item 6:  Exhibits                                                    | 15                                                                                                               |   |
|                                                                           |                                                                                                             |   |   |
| Signature                                                                      |                                                                                                             | 16     |   |
|                                                                           |                                                                                                             |   |   |

----

|                                                                                                                             |   | April 30, 2011 |       |   | October 31, 2010 |   |
|----------------------------------------------------------------------------------------------------------------------------------|--------|----------------|------------|--------|------------------|--------|
|                                                                                                                             |   | (Unaudited)    |       |   |             |   |
| ASSETS                                                                                                                           |   |           |       |   |             |   |
| Current assets:                                                                                                                  |   |           |       |   |             |   |
|    Cash and cash equivalents                                                                                      |   | $              | 1,267      |   |             | $      | 5,940 |   |
|    Accounts receivable                                                                                            |   |           | 12,391     |   |             |   | 8,864 |   |
|                                                                                                                             |   |           |       |   |             |   |   |   |
| Total current assets                                                                                                             |   |           | 13,658     |   |             |   | 14,804 |   |
|                                                                                                                             |   |           |       |   |             |   |   |   |
| Plant and equipment, net                                                                                                         |   |           | 6,266      |   |             |   | 8,034 |   |
|                                                                                                                             |   |           |       |   |             |   |   |   |
| Other assets                                                                                                                     |   |           | 26,523     |   |             |   | 50,519 |   |
|                                                                                                                             |   |           |       |   |             |   |   |   |
| Total Assets                                                                                                                     |   | $              | 46,447     |   |             | $      | 73,357 |   |
|                                                                                                                             |   |           |       |   |             |   |   |   |
| LIABILITIES AND STOCKHOLDERS' DEFICIT                                                                                            |   |           |       |   |             |   |   |   |
| Current liabilities:                                                                                                             |   |           |       |   |             |   |   |   |
| Accounts payable and accrued expenses                                                                                            |   | $              | 380,246    |   |             | $      | 373,661 |   |
| Accounts payable - related parties                                                                                               |   |           | 150,000    |   |             |   | 150,000 |   |
| Notes payable - related parties                                                                                                  |   |           | 51,936     |   |             |   | 51,936 |   |
| Deferred revenue                                                                                                                 |   |           | 210,950    |   |             |   | 174,700 |   |
|                                                                                                                             |   |           |       |   |             |   |   |   |
| Total Current Liabilities                                                                                                        |   |           | 793,132    |   |             |   | 750,297 |   |
|                                                                                                                             |   |           |       |   |             |   |   |   |
| Contingencies                                                                                                                    |   |           |       |   |             |   |   |   |
|                                                                                                                             |   |           |       |   |             |   |   |   |
| Stockholders' deficit:                                                                                                           |   |           |       |   |             |   |   |   |
| Preferred stock, $.0001 par value, 5,200 shares authorized, none issued and outstanding, respectively                            |   |           | -          |   |             |   | - |   |
| Series A- Convertible Preferred Stock $0.0001 par value, 2,400 shares authorized, 80 and 80 issued and outstanding, respectively |   |           | 1          |   |             |   | 1 |   |
| Series B- Convertible Preferred Stock $0.0001 par value, 2,400 shares authorized, 974 and 974 shares issued and outstanding      |   |           | 1          |   |             |   | 1 |   |
| Common stock, $.0001 par value: 750,000,000                                                                                      |   |           | 54,777     |   |             |   | 54,777 |   |
| shares authorized, 547,769,915 shares issued and 547,769,915 outstanding, respectively                                           |   |           |       |   |             |   |   |   |
| Additional paid-in capital                                                                                                       |   |           | 7,968,873  |   |             |   | 7,968,873 |   |
| Treasury stock at cost (500,000 Shares)                                                                                          |   |           | (2,025     | )      |             |   | (2,025 | ) |
| Accumulated deficit                                                                                                              |   |           | (8,768,312 | )      |             |   | (8,698,567 | ) |
| Total stockholders' deficit                                                                                                      |   |           | (746,685   | )      |             |   | (676,940 | ) |
|                                                                                                                             |   |           |       |   |             |   |   |   |
| Total Liabilities and Stockholders' Deficit                                                                                      |   | $              | 46,447     |   |             | $      | 73,357 |   |

----

|                                  |   | Three Months   |        |   | Three Months   |   |        | Six Months     |   |   | Six Months     |   |
|---------------------------------------|--------|----------------|-------------|--------|----------------|--------|-------------|----------------|--------|--------|----------------|--------|
|                                  |   | Ended          |        |   | Ended          |   |        | Ended          |   |   | Ended          |   |
|                                  |   | April 30, 2011 |        |   | April 30, 2010 |   |        | April 30, 2011 |   |   | April 30, 2010 |   |
| Net Sales                             |   | $              | 87,268      |   |           | $      | 61,413      |           |   | $      | 151,888        |   |   | $ | 157,628 |   |
| Cost of Goods Sold                    |   |           | 10,207      |   |           |   | 9,095       |           |   |   | 13,743         |   |   |   | 10,401 |   |
|                                  |   |           |        |   |           |   |        |           |   |   |           |   |   |   |   |   |
| GROSS PROFIT                          |   |           | 77,061      |   |           |   | 52,318      |           |   |   | 138,145        |   |   |   | 147,227 |   |
|                                  |   |           |        |   |           |   |        |           |   |   |           |   |   |   |   |   |
| Costs and Expenses                    |   |           |        |   |           |   |        |           |   |   |           |   |   |   |   |   |
| Research and development costs        |   |           | 49,359      |   |           |   | 70,474      |           |   |   | 87,224         |   |   |   | 133,406 |   |
| Selling, general and administrative   |   |           | 64,379      |   |           |   | 56,491      |           |   |   | 124,305        |   |   |   | 107,238 |   |
| Depreciation and Amortization         |   |           | 1,259       |   |           |   | 6,824       |           |   |   | 4,056          |   |   |   | 11,149 |   |
|                                  |   |           |        |   |           |   |        |           |   |   |           |   |   |   |   |   |
| Total costs and expenses              |   |           | 114,997     |   |           |   | 133,789     |           |   |   | 215,585        |   |   |   | 251,793 |   |
|                                  |   |           |        |   |           |   |        |           |   |   |           |   |   |   |   |   |
| Operating loss                        |   |           | (37,936     | )      |           |   | (81,471     | )              |   |   | (77,440        | )      |   |   | (104,566 | ) |
|                                  |   |           |        |   |           |   |        |           |   |   |           |   |   |   |   |   |
| Other income (expense):               |   |           |        |   |           |   |        |           |   |   |           |   |   |   |   |   |
| Other income                          |   |           | -           |   |           |   | -           |           |   |   | 2,958          |   |   |   | 1,333 |   |
| Interest expense                      |   |           | (969        | )      |           |   | (1,248      | )              |   |   | (2,496         | )      |   |   | (2,496 | ) |
|                                  |   |           |        |   |           |   |        |           |   |   |           |   |   |   |   |   |
| Total other income (expense)          |   |           | (969        | )      |           |   | (1,248      | )              |   |   | 462            |   |   |   | (1,163 | ) |
|                                  |   |           |        |   |           |   |        |           |   |   |           |   |   |   |   |   |
| Net loss before income tax provision  |   |           | (38,905     | )      |           |   | (82,719     | )              |   |   | (76,978        | )      |   |   | (105,729 | ) |
|                                  |   |           |        |   |           |   |        |           |   |   |           |   |   |   |   |   |
| Provision for income taxes            |   |           | -           |   |           |   | -           |           |   |   | -              |   |   |   | - |   |
| Refundable tax credit                 |   |           | 3,855       |   |           |   | 4,941       |           |   |   | 7,233          |   |   |   | 10,561 |   |
|                                  |   |           |        |   |           |   |        |           |   |   |           |   |   |   |   |   |
| Net loss                              |   | $              | (35,050     | )      |           | $      | (77,778     | )              |   | $      | (69,745        | )      |   | $ | (95,168 | ) |
|                                  |   |           |        |   |           |   |        |           |   |   |           |   |   |   |   |   |
| Loss per share - basic and diluted    |   |           | (0.01       | )      |           |   | (0.01       | )              |   |   | (0.01          | )      |   |   | (0.02 | ) |
| Weighted average shares outstanding - |   |           | 547,769,915 |   |           |   | 547,769,915 |           |   |   | 547,769,915    |   |   |   | 547,769,915 |   |
| basic and diluted                     |   |           |        |   |           |   |        |           |   |   |           |   |   |   |   |   |

----

|                                                              |   | Six Months     |    |   | Six Months     |   |
|-------------------------------------------------------------------|--------|----------------|---------|--------|----------------|--------|
|                                                              |   | Ended          |    |   | Ended          |   |
|                                                              |   | April 30, 2011 |    |   | April 30, 2010 |   |
| Cash Flows from Operating Activities:                             |   |           |    |   |           |   |
| Net loss                                                          |   | $              | (69,745 | )      |           | $      | (95,168 | ) |
| Adjustments to reconcile net loss to net cash provided by         |   |           |    |   |           |
| (used in) operating activities:                                   |   |           |    |   |           |   |   |   |
| Accumulated depreciation and amortization                         |   |           | 4,056   |   |           |   | 11,149 |   |
| Changes in Operating Assets and Liabilities                       |   |           |    |   |           |   |   |   |
| Accounts receivable                                               |   |           | (3,527  | )      |           |   | (6,959 | ) |
| Other assets                                                      |   |           | 23,996  |   |           |   | (10,561 | ) |
| Prepaid expenses                                                  |   |           | -       |   |           |   | 8,011 |   |
| Accounts payable and accrued liabilities                          |   |           | 6,585   |   |           |   | 150,093 |   |
| Deferrecd revenue                                                 |   |           | 36,250  |   |           |   | 93,500 |   |
| Net cash provided by (used in)  operating activities    |   |           | (2,385  | )      |           |   | 150,065 |   |
|                                                              |   |           |    |   |           |   |   |   |
| Cash Flows from Investing Activities:                             |   |           |    |   |           |   |   |   |
| Purchases of marketable equitable securities                      |   |           | -       |   |           |   | - |   |
| Proceeds from sales of  marketable equitable securities |   |           | -       |   |           |   | - |   |
| Purchases of fixed assets                                         |   |           | (2,288  | )      |           |   | (150,000 | ) |
| Net cash used in investing activities                             |   |           | (2,288  | )      |           |   | (150,000 | ) |
|                                                              |   |           |    |   |           |   |   |   |
| Cash Flows from Financing Activities:                             |   |           |    |   |           |   |   |   |
| Net cash provided by (used in) financing activities               |   |           | -       |   |           |   | - |   |
|                                                              |   |           |    |   |           |   |   |   |
| Net increase (decrease) in cash and cash equivalents              |   |           | (4,673  | )      |           |   | 65 |   |
| Cash and cash equivalents, beginning of the period                |   |           | 5,940   |   |           |   | 3,135 |   |
| Cash and cash equivalents, end of the period                      |   | $              | 1,267   |   |           | $      | 3,200 |   |
|                                                              |   |           |    |   |           |   |   |   |
|                                                              |   |           |    |   |           |   |   |   |
| Cash paid for interest                                            |   | $              | -       |   |           | $      | - |   |
| Cash paid for taxes                                               |   | $              | -       |   |           | $      | - |   |

----

----

|                  |   |  April 30,  |      |   | April 30, |   |
|-----------------------|--------|-----------------------|-----------|--------|-----------|--------|
|                  |   | 2011                  |      |   | 2010      |   |
| Raw Materials         |   | $                     | 19,338    |   |      | $      | 19,338 |   |
| Work In Process       |   |                  | 742,736   |   |      |   | 742,736 |   |
| Inventory Asset       |   |                  | 72,771    |   |      |   | 76,751 |   |
| Finished Goods        |   |                  | 61,771    |   |      |   | 61,771 |   |
|                  |   |                  | 896,616   |   |      |   | 900,596 |   |
|                  |   |                  |      |   |      |   |   |   |
| Inventories Allowance |   |                  | (896,616) |   |      |   | (900,596) |   |
|                  |   | $                     | -         |   |      | $      | - |   |

----

|       |   | 2011   |   |   | 2010   |   |
|------------|--------|--------|--------|--------|--------|--------|
| Customer A |   |   | 31%    |   |   |   | N/A |   |
| Customer B |   |   | 17%    |   |   |   | 15% |   |
| Customer C |   |   | N/A    |   |   |   | 20% |   |

|       |   | 2011   |   |   | 2010   |   |
|------------|--------|--------|--------|--------|--------|--------|
| Customer A |   |   | 20%    |   |   |   | 46% |   |

----

----

| The Company has an unsecured demand notes payable – shareholder bearing an annual interest rate of 10% due on March 31, 2004. The notes are currently past maturity; however no demand for payment has been made.                      |   | $      | 41,936 |   |
|----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|--------|--------|--------|--------|
| The Company has an unsecured demand notes payable – shareholder bearing an annual interest rate of 8% due on various dates through March 26, 2006. The notes are currently past maturity; however no demand for payment has been made. |   |   | 10,000 |   |
| Total notes payable, related parties                                                                                                                                                                                                         |   | $      | 51,936 |   |

| (A)            | Preferred Stock- The Company has 5,200 preferred shares authorized to be issued with the rights and preferences to be determined by the Board of Directors as of April 30, 2010 and 2011. |
|-----------------------------------------------------------------------|-------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|

| (B)            | Stock Options- On November 7, 2004 the Board of Directors adopted the 2004 Stock Option Plan, authorizing issuance of options on up to 60 million shares of the Company’s common stock.  In December of 2004, the Board approved issuance of options to purchase approximately 48,000,000 shares of its common stock to existing officers, directors and employees, subject to shareholder approval of the plan. In May 2005, such approval was received. The fair value of the options on the grant date was $480,000 calculated using the Black-Scholes Option Pricing Model. As of April 30, 2011 approximately 11,215,000 were deemed vested based on length of service with the Company since the date the Company’s Plan of Reorganization was approved. Terminated employees who have elected not to exercise options have forfeited their options. Approximately 37,000,000 total options have been forfeited since the adoption of the Stock Option Plan. |
|-----------------------------------------------------------------------|------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|

|                                |   | Number of Shares |        |   | Weighted Average Exercise Price |   |
|-------------------------------------|--------|------------------|-------------|--------|---------------------------------|--------|
| Options outstanding, April 30, 2009 |   |             | 12,430,000  |   |                            | $      | 0.01 |   |
| Options granted                     |   |             | -           |   |                            |   | - |   |
| Options exercised                   |   |             | -           |   |                            |   | - |   |
| Options forfeited                   |   |             | (1,215,000) |   |                            |   | 0.01 |   |
| Options outstanding, April 30, 2010 |   |             | 11,215,000  |   |                            | $      | 0.01 |   |
| Options granted                     |   |             | -           |   |                            |   | - |   |
| Options exercised                   |   |             | -           |   |                            |   | - |   |
| Options forfeited                   |   |             | -           |   |                            |   | - |   |
| Options outstanding, April 30, 2011 |   |             | 11,215,000  |   |                            | $      | 0.01 |   |

----

| April 30, 2011 Options Outstanding |   |   | Options Exercisable                |   |
|-----------------------------------------|--------|--------|------------------------------------|--------|
| Range ofExercise Price                  |   |   | NumberOutstanding atApril 30, 2011 |   | Weighted Average Remaining Contractual Life |   | Weighted Average Exercise Price |   |   | NumberExercisable atApril 30, 2011 |   |   | Weighted Average Exercise Price |   |
| $                                       | .01    |   |                               |   | 11,215,000 |   | 2.08 years |   | $ | .01 |   |   |   | 11,215,000 |   |   | $ | .01 |   |

| April 30, 2010 Options Outstanding |   |   | Options Exercisable                |
|------------------------------------|--------|--------|------------------------------------|
| Range of Exercise Price       |   |   | NumberOutstanding atApril 30, 2010 |   | Weighted Average Remaining Contractual Life |   | Weighted Average Exercise Price |   |   | NumberExercisable atApril 30, 2010 |   |   | Weighted Average Exercise Price |   |
| $                                  | .01    |   |                               |   | 11,215,000 |   | 3.08 years |   | $ | .01 |   |   |   | 11,215,000 |   |   | $ | .01 |   |

----

----

----

----

| 31.1 | Certification of Chief Executive Officer pursuant to Rule 13a – 14 (a) of the Securities Exchange Act of 1934 (filed herewith electronically). |
|------|------------------------------------------------------------------------------------------------------------------------------------------------------|

| 31.2 | Certification of Principal Financial and Accounting Officer pursuant to Rule 13a – 14 (a) of the Securities Exchange Act of 1934 (filed herewith electronically). |
|------|-------------------------------------------------------------------------------------------------------------------------------------------------------------------------|

| 32.1 | Certification of Chief Executive Officer pursuant to 18 U.S.C. Section 1350, as adopted to Section 906 of the Sarbanes-Oxley Act of 2002 (filed herewith electronically). |
|------|---------------------------------------------------------------------------------------------------------------------------------------------------------------------------|

| 32.2 | Certification of Principal Financial and Accounting Officer pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes – Oxley Act of 2002 (filed herewith electronically) |
|------|--------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|

----

|                | MERA PHARMACEUTICALS, INC. |                               |
|---------------------|----------------------------|------------------------------------|
|                |                       |                               |   |
| Date: July 25, 2012 | By:                        | /s/ Charles Gary Spaniak, Sr. |   |
|                |                       | Charles Gary Spaniak, Sr.          |   |
|                |                       | Chief Executive Officer            |   |
|                |                       |                               |   |

|   | By:    | /s/ Lawrence H. Wolfe                 |   |
|--------|--------|--------------------------------------------|--------|
|   |   | Lawrence H. Wolfe                          |   |
|   |   | Principal Financial and Accounting Officer |   |